BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32388741)

  • 1. Treatment and Survival of Elderly Patients with Stage I-II Pancreatic Cancer: A Report of the EURECCA Pancreas Consortium.
    Groen JV; Douwes TA; van Eycken E; van der Geest LGM; Johannesen TB; Besselink MG; Koerkamp BG; Wilmink JW; Bonsing BA; Portielje JEA; van de Velde CJH; Bastiaannet E; Mieog JSD;
    Ann Surg Oncol; 2020 Dec; 27(13):5337-5346. PubMed ID: 32388741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium.
    Groen JV; Sibinga Mulder BG; van Eycken E; Valerianova Z; Borras JM; van der Geest LGM; Capretti G; Schlesinger-Raab A; Primic-Zakelj M; Ryzhov A; van de Velde CJH; Bonsing BA; Bastiaannet E; Mieog JSD
    Ann Surg Oncol; 2018 Nov; 25(12):3492-3501. PubMed ID: 30151560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and prognostic factors in patients with pancreatic squamous cell carcinoma.
    Tella SH; Kommalapati A; Yadav S; Bergquist JR; Truty MJ; Durgin L; Ma WW; Cleary SP; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Sep; 45(9):1700-1705. PubMed ID: 31118133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and Long-Term Outcomes of Pancreatic Cancer Resection in Elderly Patients: A Nationwide Analysis.
    Henry AC; Schouten TJ; Daamen LA; Walma MS; Noordzij P; Cirkel GA; Los M; Besselink MG; Busch OR; Bonsing BA; Bosscha K; van Dam RM; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Kazemier G; Liem MS; de Meijer VE; Nieuwenhuijs VB; Roos D; Schreinemakers JMJ; Stommel MWJ; Molenaar IQ; van Santvoort HC;
    Ann Surg Oncol; 2022 Sep; 29(9):6031-6042. PubMed ID: 35653069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer.
    Kagedan DJ; Abraham L; Goyert N; Li Q; Paszat LF; Kiss A; Earle CC; Mittmann N; Coburn NG
    Cancer; 2016 Oct; 122(20):3175-3182. PubMed ID: 27391466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
    Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
    Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Care Versus Oncology-Based Surveillance Following Adjuvant Chemotherapy in Resected Pancreatic Cancer.
    Samawi HH; Yin Y; Lim HJ; Cheung WY
    J Gastrointest Cancer; 2018 Dec; 49(4):429-436. PubMed ID: 28674913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.
    van Erning FN; Mackay TM; van der Geest LGM; Groot Koerkamp B; van Laarhoven HWM; Bonsing BA; Wilmink JW; van Santvoort HC; de Vos-Geelen J; van Eijck CHJ; Busch OR; Lemmens VE; Besselink MG;
    Acta Oncol; 2018 Dec; 57(12):1655-1662. PubMed ID: 30264642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
    Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
    Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis.
    Mollberg N; Rahbari NN; Koch M; Hartwig W; Hoeger Y; Büchler MW; Weitz J
    Ann Surg; 2011 Dec; 254(6):882-93. PubMed ID: 22064622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radical resection in patients with pancreatic head carcinomas. A retrospective survival analysis in a group of 307 subjects].
    Ryska M; Strnad R; Belina F; Zavoral M; Sálek C; Hrabal P; Buric I; Lásziková E; Kvicerová H; Jurenka B; Holcátová I
    Rozhl Chir; 2007 Aug; 86(8):432-9. PubMed ID: 17969981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania.
    Breugom AJ; Bastiaannet E; Boelens PG; Iversen LH; Martling A; Johansson R; Evans T; Lawton S; O'Brien KM; Van Eycken E; Janciauskiene R; Liefers GJ; Cervantes A; Lemmens VE; van de Velde CJ
    Eur J Cancer; 2016 Aug; 63():110-7. PubMed ID: 27299663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.
    Ma SJ; Iovoli AJ; Hermann GM; Prezzano KM; Singh AK
    Cancer Med; 2019 Aug; 8(9):4110-4123. PubMed ID: 31183965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
    Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M
    Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
    Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
    J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
    Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
    World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
    Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG
    Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative outcomes in elderly patients undergoing pancreatic resection for pancreatic adenocarcinoma: A systematic review and meta-analysis.
    Tan E; Song J; Lam S; D'Souza M; Crawford M; Sandroussi C
    Int J Surg; 2019 Dec; 72():59-68. PubMed ID: 31580919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer.
    Gruhl JD; Garrido-Laguna I; Francis SR; Affolter K; Tao R; Lloyd S
    Cancer Med; 2020 Mar; 9(5):1703-1711. PubMed ID: 31945808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matched-Pairs Analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan.
    Satoi S; Murakami Y; Motoi F; Sho M; Matsumoto I; Uemura K; Kawai M; Kurata M; Yanagimoto H; Yamamoto T; Mizuma M; Unno M; Kinoshita S; Akahori T; Shinzeki M; Fukumoto T; Hashimoto Y; Hirono S; Yamaue H; Honda G; Kwon M
    Pancreas; 2016 Aug; 45(7):1003-9. PubMed ID: 26692442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.